What factors of GLP-1 coverage drive up premiums Using data from MarketScan and research by Blue Health Intelligence (BHI), the EBRI report models how GLP-1 coverage could affect employer-sponsored insurance premiums, exploring several scenarios based on: Drug pricing Net costs range from $617 to $766 per 30-day supply Patient adherence Perfect adherence leads to higher premiums due to sustained drug use Eligibility criteria Including overweight individuals with at least one weight-related condition significantly increases cost burden Cost-sharing Cost-sharing structures such as $90 copays help but dont eliminate increases Usage is growing More than 57 million privately insured adults qualify for GLP-1 drugs, like Ozempic and Wegovy
Ive struggled with late-night cravings forever, and these patches have made such a difference
The first randomized, double-blind, placebo-controlled trial using liraglutide after MBS was performed by Lofton et al
doi: 10.1038/s41380-020-0645-4Google ScholarPubMed Pulvirenti, G., Valerio, C., Spadaro, F., D'Agata, V., Freni, V., Nardo, L., & Drago, F